Farnum Rhondainsider trades
In SEC Form 4 filings, Farnum Rhonda is listed as SVP, COMM & MEDICAL AFFAIRS of Theravance Biopharma, Inc. (TBPH). In the last 90 days, Farnum Rhonda sold $226.8K of Theravance Biopharma, Inc. (TBPH) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TBPHTheravance Biopharma, Inc. | SVP, COMM & MEDICAL AFFAIRS | 7 | Sep 24 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D | 124,414 | not reported | not reported | 89,062 | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D | 89,062 | not reported | not reported | not reported | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D · derivative | 150,000 | $25.64 | $3,846,000 | not reported | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 15 | Sep 17 | S | 3,329 | $17.03 | Sale −$56,707 | 223,461 | Yes | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 15 | Sep 17 | S | 3,328 | $17.03 | Sale −$56,690 | 220,133 | Yes | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 15 | Sep 17 | S | 6,657 | $17.03 | Sale −$113,397 | 213,476 | Yes | Form 4 |
| TBPHTheravance Biopharma, Inc. | Aug 20 | Aug 24 | F | 5,667 | $16.95 | $96,056 | 226,790 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.